Commentary · 1 Jul 2026
Conference abstractPublished 26 Oct 2016
A mutant mouse model of Hajdu-Cheney syndrome
UConn Health, USA
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Hajdu-Cheney syndrome (HCS) is a rare but devastating genetic disease characterized by craniofacial developmental abnormalities, acro-osteolysis, severe osteoporosis with fractures and sudden death. HCS is associated with a gain-of-function of NOTCH2, where point mutations in exon 34 lead to a truncated and stable NOTCH2 protein product. To study and understand HCS, we created a mouse model harboring a Notch2 mutant allele reproducing the mutation found in subjects with HCS. The 6955C>T mutation in mice created a stop codon at glutamic acid 2319, upstream the PEST domain which is required for Notch degradation. Sequences necessary for Notch2 transcriptional activity are preserved. The 6955C>T mutation was introduced into the Notch2 locus by homologous recombination, verified by DNA sequencing and mice characterized following removal of the selection cassette. Notch target genes were induced in tissues of HCS-Notch2 mice, demonstrating Notch signal activation. Homozygous HCS-Notch2 mutants exhibited newborn lethality, whereas heterozygous mice had pronounced bone loss. Micro-computed tomography of HCSNotch2 mutants revealed a 50-55% decrease in cancellous bone volume and markedly decreased connectivity. Cortical thickness, total and cortical cross-sectional areas were decreased by 20-40%. Histomorphometry revealed increased osteoclast number and bone resorption and only a modest decrease in bone formation. Bone marrow mononuclear cells had an increased capacity to form multinucleated osteoclastsin response to M-CSF and RANK-L, explaining the enhanced bone resorption. Osteoblast cultures exhibited increased RANK-L mRNA. In conclusion, a genetically engineered HCS mutant mouse model recreates the human disease and exhibits pronounced osteopenia due to an increased osteoclastogenesis and bone resorption. For the first time, the skeletal pathogenesis of HCS is explained.
Subjects
Genetics & Molecular BiologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Genetic Syndromes & Gene Therapy.
Perspective · 1 Jul 2026
Lentiviral Gene Integration Systems in Hematologic Genetic Blood Disorders
Perspective · 1 Jul 2026
Programmable RNA Editing Systems in Congenital Skeletal Dysplasia Disorders
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Genetic Syndromes & Gene Therapy
- SubjectGenetics & Molecular Biology
- BylineArticles whose byline prints “Canalis E”
